People: Oaktree Capital Group LLC (OAK)

OAK on New York Consolidated

49.78USD
28 Aug 2014
Price Change (% chg)

$-0.17 (-0.34%)
Prev Close
$49.95
Open
$49.58
Day's High
$50.00
Day's Low
$49.58
Volume
90,996
Avg. Vol
274,890
52-wk High
$62.30
52-wk Low
$47.36

Search Stocks

Denham, Robert 

Brief Biography

Mr. Robert E. Denham is Director of Oaktree Capital Group LLC. Mr. Denham is a partner in the law firm of Munger, Tolles & Olson LLP, having rejoined the firm as a partner in 1998 to advise clients on strategic and financial issues, after serving as the Chairman and Chief Executive Officer of Salomon Inc. Mr. Denham joined Salomon in late August 1991 as General Counsel of Salomon and its subsidiary, Salomon Brothers, and became Chairman and CEO of Salomon in June 1992. Prior to joining Salomon, Mr. Denham had been at Munger, Tolles & Olson LLP for twenty years, including five years as managing partner. Mr. Denham graduated magna cum laude from the University of Texas, where he was elected to Phi Beta Kappa. He received a master's degree in Government from Harvard University in 1968 and a J.D. from Harvard Law School in 1971, where he graduated magna cum laude and was a Case and Developments Editor of the Harvard Law Review. Mr. Denham is a member of the California, American and Los Angeles County Bar Associations. Mr. Denham serves on the board of directors of the Russell Sage Foundation (Chair) and the James Irvine Foundation and is a trustee of the Good Samaritan Hospital of Los Angeles (Vice Chairman). He is also a public member of the Professional Ethics Executive Committee of the American Institute of Certified Public Accountants. Mr. Denham presently serves on the boards of the Chevron Corporation, Fomento Economico Mexicano, S.A. de CV (FEMSA), The New York Times and UGL Limited. Mr. Denham previously served on the board of Wesco Financial Corporation.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Howard Marks

--

Bruce Karsh

43,510,000

Lawrence Keele

--

Sheldon Stone

--

David Kirchheimer

11,514,600

Susan Gentile

--
As Of 30 Dec 2013
Search Stocks